Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Gross Margin (2016 - 2025)

Surgery Partners' Gross Margin history spans 12 years, with the latest figure at 17.41% for Q4 2025.

  • For Q4 2025, Gross Margin fell 5679.0% year-over-year to 17.41%; the TTM value through Dec 2025 reached 73.44%, down 479.0%, while the annual FY2025 figure was 73.44%, 46.0% down from the prior year.
  • Gross Margin for Q4 2025 was 17.41% at Surgery Partners, down from 94.04% in the prior quarter.
  • Across five years, Gross Margin topped out at 154.49% in Q4 2021 and bottomed at 16.15% in Q4 2022.
  • The 5-year median for Gross Margin is 73.83% (2024), against an average of 81.31%.
  • The largest annual shift saw Gross Margin plummeted -13834bps in 2022 before it soared 13477bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 154.49% in 2021, then tumbled by -90bps to 16.15% in 2022, then soared by 834bps to 150.92% in 2023, then crashed by -51bps to 74.2% in 2024, then tumbled by -77bps to 17.41% in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Gross Margin are 17.41% (Q4 2025), 94.04% (Q3 2025), and 93.29% (Q2 2025).